ReviewHuman vaccines & immunotherapeutics2023
Malawi vaccination drive: An integrated immunization campaign against typhoid, measles, rubella, and polio; health benefits and potential challenges.
Review in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 16 citations in OpenAlex.
- Country readiness in responding to COVID-19 Vaccine-Related Events (VREs) in Malawi.Malawi medical journal : the journal of Medical Association of Malawi · 2026Article
- Digitising payments for campaign health workers in Africa: the promise and the path to sustainable scale.BMJ global health · 2026Article
- Article
- Characteristics of Studies Focusing on Vaccine Series Completion Among Children Aged 12-23 Months in Sub-Saharan Africa: A Scoping Review.Children (Basel, Switzerland) · 2025Review
- Socio-demographic disparities in basic under-two immunization coverage: insights from the 2016 Malawi demographic and health survey.BMC public health · 2025Article
- Embracing change, moving with time: exploring the role of digital technologies and accelerators in promoting community oral health in Africa.Frontiers in oral health · 2025Article
- Addressing the re-emergence and resurgence of vaccine-preventable diseases in Africa: A health equity perspective.Human vaccines & immunotherapeutics · 2024Review
- Understanding the barriers and facilitators related to never treatment during mass drug administration among mobile and migrant populations in Mali: a qualitative exploratory study.BMJ global health · 2024Article
- Article
- Perceptions of the COVID-19 Vaccine and Other Adult Vaccinations in Malawi: A Qualitative Assessment.Global health, science and practice · 2024Article
- Knowledge, Attitude, and Practice Towards Child Immunisation Among Mothers Attending Magu District Hospital, Mwanza.The East African health research journal · 2024Article
- A retrospective review of the common childhood illnesses and the indications for antibiotic prescription at community hospital in Malawi.Frontiers in antibiotics · 2024Article
- Vaccine hesitancy in Malawi: a threat to already-made health gains.Annals of medicine and surgery (2012) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vaccination stands as one of the most important scientific discoveries and public health achievements in the fight against diseases. For over a century, millions of early childhood deaths have been averted through routine immunizations. However, to prevent the morbidity and mortality associated with vaccine-preventable diseases and their complications and optimize the control of vaccine-preventable diseases in communities, high uptake rates must be achieved. Mass immunization campaigns (MICs) have globally been used to introduce new vaccines for major infectious diseases and improve coverage of routine vaccines through catch-up campaigns. Malawi recently undertook such a campaign to introduce a highly efficacious typhoid conjugate vaccine and provides a catch-up to measles, rubella, and polio. Such campaigns are associated with multiple benefits. However, the MICs are associated with multiple challenges to be successfully administered. In this review, we highlight recent MIC, vaccine coverage, and potential challenges and benefits and offer recommendation for future preventive campaigns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.